Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-03), Evonik Industries AG's 12-1 Month Momentum % is 22.94%.
The industry rank for Evonik Industries AG's 12-1 Month Momentum % or its related term are showing as below:
XSWX:EVK's 12-1 Month Momentum % is ranked worse than 61.45% of 1611
companies
in the Chemicals industry
Industry Median: 1.43
vs XSWX:EVK: 22.94
Evonik Industries AG (XSWX:EVK) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Evonik Industries AG 12-1 Month Momentum % Related Terms
XSWX:EVK vs LIN, SHW, ECL: 12-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, Evonik Industries AG's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evonik Industries AG 12-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Evonik Industries AG's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Evonik Industries AG's 12-1 Month Momentum % falls into.
Evonik Industries AG (XSWX:EVK) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evonik Industries AG (XSWX:EVK) has a 12-1 Month Momentum % of 22.94% as of Aug. 03, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Evonik Industries AG and its competitors. According to the industry distribution chart, Evonik Industries AG ranks #990 out of 1611 companies in the Chemicals industry, placing it in the top 61.5%.
Is Evonik Industries AG's 12-1 Month Momentum % too high?
Evonik Industries AG's current 12-1 Month Momentum % is 22.94%. The Chemicals industry median 12-1 Month Momentum % is 1.43. Evonik Industries AG's value of 22.94% is 1504.2% above this industry median. Based on the distribution chart, Evonik Industries AG ranks #990 out of 1611 companies in the Chemicals industry, which is below the industry midpoint. Overall, Evonik Industries AG has a GF Score™ of 16/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's 12-1 Month Momentum % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Evonik Industries AG ranks #990 out of 1611 companies for 12-1 Month Momentum %. This places Evonik Industries AG in the lower half of its industry. The industry median 12-1 Month Momentum % is 1.43. Evonik Industries AG's value of 22.94% is 1504.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Chemicals company?
The median 12-1 Month Momentum % among Chemicals companies is 1.43, based on 1,611 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evonik Industries AG's current 12-1 Month Momentum % of 22.94% is 1504.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Evonik Industries AG and its competitors. For the Chemicals industry, the median 12-1 Month Momentum % is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evonik Industries AG's current 12-1 Month Momentum % is 22.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Based on GuruFocus' analysis, Evonik Industries AG (XSWX:EVK) is currently considered Fairly Valued. The stock's GF Value™ is CHF14.49, compared to a current price of CHF15.92 — trading 9.9% above its estimated fair value. The current 12-1 Month Momentum % is 22.94% and 1504.2% above the Chemicals industry median of 1.43. Evonik Industries AG's overall GF Score™ is 16/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Evonik Industries AG (XSWX:EVK), the current 12-1 Month Momentum % is 22.94% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evonik Industries AG (XSWX:EVK) Overvalued in 2026?
Based on GuruFocus' analysis, Evonik Industries AG stock appears to be overvalued.
The current stock price of CHF15.92 is trading 9.9% above its estimated GF Value™ of CHF14.49.
GuruFocus considers Evonik Industries AG to be Fairly Valued.
Key valuation signals for XSWX:EVK:
12-1 Month Momentum %: 22.94%
GF Value™: CHF14.49 vs. price of CHF15.92 (9.9% above fair value)
Industry Position: 1504.2% above the Chemicals median (#990 of 1611)
No single metric tells the full story. See the XSWX:EVK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
16GF Score
Get the complete analysis for XSWX:EVK
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EVK has been successfully added to your 
